The Innate Immune System of the Perinatal Lung and Responses to Respiratory Syncytial Virus Infection

Veterinary Pathology

Volumn 50, Issue 5, 2013, Pages 827-841

  Derscheid, R J ^a   Ackermann, M R ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

innate immunity; lung; pneumonia; respiratory syncytial virus (RSV)

Indexed keywords

SCGB1A1 PROTEIN, HUMAN; UTEROGLOBIN;

AGE; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CYTOLOGY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LUNG; METABOLISM; MONONUCLEAR PHAGOCYTE; NEWBORN; PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS (RSV); RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIROLOGY;

INNATE IMMUNITY; LUNG; PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS (RSV);

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; LUNG; MODELS, BIOLOGICAL; MONONUCLEAR PHAGOCYTE SYSTEM; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; UTEROGLOBIN;

EID: 84883646355     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985813480216     Document Type: Article

References (145)

1. Amanatidou V,Sourvinos G,Apostolakis S, et al.RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis.Pediatr Infect Dis J. 2008;27:38-42.
2. Ambruso DR,Bentwood B,Henson PM, et al.Oxidative metabolism of cord blood neutrophils: relationship to content and degranulation of cytoplasmic granules.Pediatr Res. 1984;18:1148-1153.
3. Ampuero S,Luchsinger V,Tapia L, et al.SP-A1, SP-A2 and SP-D gene polymorphisms in severe acute respiratory syncytial infection in Chilean infants.Infect Genet Evol. 2011;11:1368-1377.
4. Assefa D,Amin N,Dozor AJ, et al.Attenuated interleukin-8/leukocyte immunoresponse in preterm infants compared with term infants hospitalized with respiratory syncytial virus bronchiolitis: a pilot study.Hum Immunol. 2011;72:708-711.
5. Ashcroft GS.Bidirectional regulation of macrophage function by TGF-beta.Microbes Infect. 1999;1:1275-1282.
6. Atreya PL,Kulkarni S.Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA.Virology. 1999;261:227-241.
7. Awomoyi AA,Rallabhandi P,Pollin TI, et al.Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children.J Immunol. 2007;179:3171-3177.
8. Barlow PG,Beaumont PE,Cosseau C, et al.The human cathelicidin Ll-37 preferentially promotes apoptosis of infected airway epithelium.Am J Respir Cell Mol Biol. 2010;43:692-702.
9. Barth PJ,Wolf M,Ramaswamy A.Distribution and number of Clara cells in the normal and disturbed development of the human fetal lung.Pediatr Pathol. 1994;14:637-651.
10. Barth PJ,Koch S,Muller B, et al.Proliferation and number of Clara cell 10-kda protein (CC10)-reactive epithelial cells and basal cells in normal, hyperplastic and metaplastic bronchial mucosa.Virchows Arch. 2000;437:648-655.
11. Boers JE,Ambergen AW,Thunnissen FB.Number and proliferation of Clara cells in normal human airway epithelium.Am J Respir Crit Care Med. 1999;159:1585-1591.
12. Bonville CA,Rosenberg HF,Domachowske JB.Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection.Pediatr Allergy Immunol. 1999;10:39-44.
13. Bowdish DM,Davidson DJ,Hancock RE.Immunomodulatory properties of defensins and cathelicidins.Curr Top Microbiol Immunol. 2006;306:27-66.
14. Braido F,Riccio AM,Guerra L, et al.Clara cell 16 protein in COPD sputum: a marker of small airways damage?.Respir Med. 2007;101:2119-2124.
15. Brogden KA,Kalfa VC,Ackermann MR, et al.The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an in vivo model of pulmonary infection.Antimicrob Agents Chemother. 2001;45:331-334.
16. Bruce SR,Atkins CL,Colasurdo GN, et al.Respiratory syncytial virus infection alters surfactant protein a expression in human pulmonary epithelial cells by reducing translation efficiency.Am J Physiol Lung Cell Mol Physiol. 2009;297:L559-L567.
17. Burri PH.Fetal and postnatal development of the lung.Annu Rev Physiol. 1984;46:617-628.
18. Button B,Cai LH,Ehre C, et al.A periciliary brush promotes lung health by separating the mucus layer from airway epithelia.Science. 2012;337:937-941.
19. Castell JV,Donato MT,Gomez-Lechon MJ.Metabolism and bioactivation of toxicants in the lung: the in vitro cellular approach.Exp Toxicol Pathol. 2007;57 (suppl 1): 189-204.
20. Chieux V,Hober D,Chehadeh W, et al.MxA protein in capillary blood of children with viral infections.J Med Virol. 1999;59:547-551.
21. Collins PL,Melero JA.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.Virus Res. 2011;162:80-99.
22. Conner GE,Salathe M,Forteza R.Lactoperoxidase and hydrogen peroxide metabolism in the airway.Am J Respir Crit Care Med. 2002;166:S57-S61.
23. Derscheid RJ,Ackermann MR.Perinatal lamb model of respiratory syncytial virus (RSV) infection.Viruses. 2012;4 (10): 2359-2378.
24. Dodd JS,Clark D,Muir R, et al.Endogenous IL-21 regulates pathogenic mucosal CD4 T-cell responses during enhanced RSV disease in mice [published online November 21, 2012].Mucosal Immunol.:.
25. Domachowske JB,Bonville CA,Gao JL, et al.MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice.Cell Immunol. 2000;206:1-6.
26. Douville RN,Lissitsyn Y,Hirschfeld AF, et al.TLR4 asp299gly and thr399ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus.PLoS One. 2010;5:e12087.
27. Dubin RF,Robinson SK,Widdicombe JH.Secretion of lactoferrin and lysozyme by cultures of human airway epithelium.Am J Physiol Lung Cell Mol Physiol. 2004;286:L750-L755.
28. El Saleeby CM,Li R,Somes GW, et al.Surfactant protein A2 polymorphisms and disease severity in a respiratory syncytial virus-infected population.J Pediatr. 2009;156:409-414.
29. Elizur A,Adair-Kirk TL,Kelley DG, et al.Clara cells impact the pulmonary innate immune response to LPS.Am J Physiol Lung Cell Mol Physiol. 2007;293:L383-L392.
30. Elliott MB,Tebbey PW,Pryharski KS, et al.Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).J Med Virol. 2004;73:300-308.
31. Empey KM,Orend JG,Peebles RS, et al.Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection.PLoS One. 2012;7 (7): e40499.
32. Ermers MJ,Janssen R,Onland-Moret NC, et al.IL10 family member genes IL19 and IL20 are associated with recurrent wheeze after respiratory syncytial virus bronchiolitis.Pediatr Res. 2010;70:518-523.
33. Faber TE,Groen H,Welfing M, et al.Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis.J Med Virol. 2012;84 (7): 1084-1088.
34. Fach SJ,Brockmeier SL,Hobbs LA, et al.Pulmonary dendritic cells isolated from neonatal and adult ovine lung tissue.Vet Immunol Immun Pathol. 2007;112:171-182.
35. Fach SJ,Meyerholz DK,Gallup JM, et al.Neonatal ovine pulmonary dendritic cells support bovine respiratory syncytial virus replication with enhanced interleukin (IL)-4 and IL-10 gene transcripts.Viral Immunol. 2007;20:119-130.
36. Fach SJ,Olivier A,Gallup JM, et al.Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or Toll-like receptor ligation.Vet Immunol Immunopathol. 2010;136:55-64.
37. Fischer AJ,Lennemann NJ,Krishnamurthy S, et al.Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodide.Am J Respir Cell Mol Biol. 2011;45:874-881.
38. Fragoso MA,Fernandez V,Forteza R, et al.Transcellular thiocyanate transport by human airway epithelia.J Physiol. 2004;561:183-194.
39. Gagro A,Tominac M,Krsulovic-Hresic V, et al.Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis.Clin Exp Immunol. 2004;135:267-272.
40. Garofalo RP,Patti J,Hintz KA, et al.Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis.J Infect Dis. 2001;184:393-399.
41. Gattoni A,Parlato A,Vangieri B, et al.Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).Clin Ter. 2006;157:457-468.
42. Gill S,Wight TN,Frevert CW.Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infect.Anat Rec. 2010;293:968-981.
43. Griese M.Respiratory syncytial virus and pulmonary surfactant.Viral Immunol. 2002;15:357-363.
44. Grubor B,Gallup JM,Meyerholz DK, et al.Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs.Clin Diagn Lab Immunol. 2004;11:599-607.
45. Guerrero-Plata A,Casola A,Suarez G, et al.Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus.Am J Respir Cell Mol Biol. 2006;34:320-329.
46. Habibi MS,Opensahw PJM.Benefit and harm from immunity to respiratory syncytial virus: implications for treatment.Curr Opion Infect Dis. 2012;25:687-694.
47. Haeberle HA,Kuziel WA,Dieterich HJ, et al.Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.J Virol. 2001;75:878-890.
48. Haller O,Kochs G.Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity.J Interferon Cytokine Res. 2011;31:79-87.
49. Harty RN,Pitha PM,Okumura A.Antiviral activity of innate immune protein ISG15.J Innate Immun. 2009;1:397-404.
50. Hattori S,Shimojo N,Mashimo T, et al.Relationship between RANTES polymorphisms and respiratory syncytial virus bronchiolitis in a Japanese infant population.Jpn J Infect Dis. 2011;64:242-245.
51. Haynes LM,Moore DD,Kurt-Jones EA, et al.Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus.J Virol. 2001;75:10730-10737.
52. Hiemstra PS.The role of epithelial beta-defensins and cathelicidins in host defense of the lung.Exp Lung Res. 2007;33:537-542.
53. Hornsleth A,Loland L,Larsen LB.Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection.J Clin Virol. 2001;21:163-170.
54. Horwitz DA,Gray JD,Ohtsuka K.Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease.Microbes Infect. 1999;1:1305-1311.
55. Jafri HS,Chavez-Bueno S,Mejias A, et al.Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.J Infect Dis. 2004;189:1856-1865.
56. Janssen R,Bont L,Siezen CL, et al.Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes.J Infect Dis. 2007;196:826-834.
57. Jeffery PK,Gaillard D,Moret S.Human airway secretory cells during development and in mature airway epithelium.Eur Respir J. 1992;5:93-104.
58. John AE,Berlin AA,Lukacs NW.Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation.Eur J Immunol. 2003;33:1677-1685.
59. Johnson JE,Gonzales RA,Olson SJ, et al.The histopathology of fatal untreated human respiratory syncytial virus infection.Mod Pathol. 2007;20:108-119.
60. Johnson TR,Johnson CN,Corbett KS, et al.Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.PLoS ONE. 2011;6 (1): e16458.
61. Kawashima K,Meyerholz DK,Gallup JM, et al.Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus.Viral Immunol. 2006;19:316-323.
62. Kerr MH,Paton JY.Surfactant protein levels in severe respiratory syncytial virus infection.Am J Respir Crit Care Med. 1999;159:1115-1118.
63. Khoor A,Gray ME,Singh G, et al.Ontogeny of Clara cell-specific protein and its mRNA: their association with neuroepithelial bodies in human fetal lung and in bronchopulmonary dysplasia.J Histochem Cytochem. 1996;44:1429-1438.
64. Kim KC.Role of epithelial mucins during airway infection.Pulm Pharmacol Ther. 2012;25:415-419.
65. Kota S,Sabbah A,Chang TH, et al.Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus.J Biol Chem. 2008;283:22417-22429.
66. Krishnan S,Craven M,Welliver RC, et al.Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates.J Infect Dis. 2008;188:433-439.
67. Kristiansen H,Gad HH,Eskildsen-Larsen S, et al.The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities.J Interferon Cytokine Res. 2011;31:41-47.
68. Kurt-Jones EA,Popova L,Kwinn L, et al.Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.Nat Immunol. 2000;1:398-401.
69. Lahti M,Lofgren J,Marttila R, et al.Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection.Pediatr Res. 2002;51:696-699.
70. Lapin CD,Hiatt PW,Langston C, et al.A lamb model for human respiratory syncytial virus infection.Pediatr Pulmonol. 1993;15:151-156.
71. Larranaga CL,Ampuero SL,Luchsinger VF, et al.Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus.Pediatr Infect Dis J. 2009;28:867-873.
72. Lazic T,Sow FB,Van Geelen A, et al.Exposure to ethanol during the last trimester of pregnancy alters the maturation and immunity of the fetal lung.Alcohol. 2011;45:673-680.
73. Legrand D,Elass E,Carpentier M, et al.Interactions of lactoferrin with cells involved in immune function.Biochem Cell Biol. 2006;84:282-290.
74. Legrand D,Elass E,Pierce A, et al.Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties.Biometals. 2004;17:225-229.
75. Legrand D,Mazurier J.A critical review of the roles of host lactoferrin in immunity.Biometals. 2010;23:365-376.
76. LeVine AM,Elliott J,Whitsett JA, et al.Surfactant protein-D enhances phagocytosis and pulmonary clearance of respiratory syncytial virus.Am J Respir Cell Mol Biol. 2004;31:193-199.
77. LeVine AM,Gwozdz J,Stark J, et al.Surfactant protein-A enhances respiratory syncytial virus clearance in vivo.J Clin Invest. 1999;103:1015-1021.
78. Levy JA.The unexpected pleiotropic activities of RANTES.J Immunol. 2009;182:3945-3946.
79. Levy O.Innate immunity of the newborn: basic mechanisms and clinical correlates.Nat Rev Immunol. 2007;7:379-390.
80. Levy O,Martin S,Eichenwald E, et al.Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.Pediatrics. 1999;104:1327-1333.
81. Li HN,Barlow PG,Bylund J, et al.Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages.J Leukoc Biol. 2009;86:891-902.
82. Lindgren C,Grogaard J.Reflex apnoea response and inflammatory mediators in infants with respiratory tract infection.Acta Paediatr. 1996;85:798-803.
83. Liu P,Jamaluddin M,Li K, et al.Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.J Virol. 2007;81:1401-1411.
84. Lofgren J,Marttila R,Renko M, et al.Toll-like receptor 4 asp299gly polymorphism in respiratory syncytial virus epidemics.Pediatr Pulmonol. 2010;45:687-692.
85. Lukacs NW,Smitt JJ,Mukherjee S, et al.Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation.J Immunol. 2010;185:2231-2239.
86. Maurer M,von Stebut E.Macrophage inflammatory protein-1.Int J Biochem Cell Biol. 2004;36:1882-1886.
87. McNamara PS,Flanagan BF,Hart CA, et al.Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.J Infect Dis. 2005;191:1225-1232.
88. McNamara, Flanagan BF,Selby AM, et al.Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis.Eur Respir J. 2004;23:106-112.
89. Meyerholz DK,DeGraaff JA,Gallup JM, et al.Depletion of alveolar glycogen corresponds with immunohistochemical development of CD208 antigen expression in perinatal lamb lung.J Histochem Cytochem. 2006;54:1247-1253.
90. Meyerholz DK,Grubor B,Fach SJ, et al.Reduced clearance of respiratory syncytial virus infection in a preterm lamb model.Microbes Infect. 2004;6:1312-1319.
91. Meyerholz DK,Kawashima K,Gallup JM, et al.Expression of select immune genes (surfactant proteins A and D, sheep beta defensin 1, and Toll-like receptor 4) by respiratory epithelia is developmentally regulated in the preterm neonatal lamb.Dev Comp Immunol. 2006;30:1060-1069.
92. Meyerholz DK,Gallup JM,Lazic T, et al.Pretreatment with recombinant human vascular endothelial growth factor reduces virus replication and inflammation in a perinatal lamb model of RSV infection.Viral Immunol. 2007;20:188-196.
93. Miller AL,Bowlin TL,Lukacs NW.Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.J Infect Dis. 2004;189:1419-1430.
94. Murai H,Terada A,Mizuno M, et al.IL-10 and RANTES are elevated in nasopharyngeal secretions of children with respiratory syncytial virus infection.Allergol Int. 2007;56:157-163.
95. Murphy K,Travers P,Walport MJaneway's Immunobiology. New York: Garland; 2008:.
96. Murawski MR,Bowen GN,Cerny AM, et al.Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.J Virol. 2009;83:1492-1500.
97. Nair H,Nokes DJ,Gessner BD, et al.Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.Lancet. 2010;375:1545-1555.
98. Neilson KA,Yunis EJ.Demonstration of respiratory syncytial virus in an autopsy series.Pediatr Pathol. 1990;10:491-502.
99. Noah TL,Becker S.Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus.Clin Immunol. 2000;97:43-49.
100. Ohtsuki Y,Nakanishi N,Fujita J, et al.Immunohistochemical distribution of SP-D, compared with that of SP-A and KL-6, in interstitial pneumonias.Med Mol Morphol. 2007;40:163-167.
101. Olivier A,Gallup JM,de Macedo MM, et al.Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs.Int J Exp Pathol. 2009;90:431-438.
102. Olivier AK,Gallup JM,van Geelen A, et al.Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus A2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses.Exp Lung Res. 2011;37:131-143.
103. Olszewska-Pazdrak B,Casola A,Saito T, et al.Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus.J Virol. 1998;72:4756-4764.
104. Oshansky CM,Barber JP,Crabtree J, et al.Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells.J Infect Dis. 2010;201:1201-1207.
105. Paulus SC,Hirschfeld AF,Victor RE, et al.Common human Toll-like receptor 4 polymorphisms-role in susceptibility to respiratory syncytial virus infection and functional immunological relevance.Clin Immunol. 2007;123:252-257.
106. Perni SC,Vardhana S,Kalish R, et al.Clara cell protein 16 concentration in mid-trimester amniotic fluid: association with fetal gender, fetal G>A +38 CC16 gene polymorphism and pregnancy outcome.J Reprod Immunol. 2005;68:85-90.
107. Pfaller CK,Li Z,George CX, et al.Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response.Curr Opin Immunol. 2011;23:573-582.
108. Plopper CG,Mariassy AT,Hill LH.Ultrastructure of the nonciliated bronchiolar epithelial (Clara) cell of mammalian lung, I: a comparison of rabbit, guinea pig, rat, hamster, and mouse.Exp Lung Res. 1980;1:139-154.
109. Puthothu B,Forster J,Heinzmann A, et al.TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease.Dis Markers. 2006;22:303-308.
110. Qing G,Rajaraman K,Bortolussi R.Diminished priming of neonatal polymorphonuclear leukocytes by lipopolysaccharide is associated with reduced CD14 expression.Infect Immun. 1995;63:248-252.
111. Rallabhandi P,Phillips RL,Boukhvalova MS, et al.Respiratory syncytial virus fusion protein-induced Toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.MBio. 2012;3:218-212.
112. Ramsay PL,DeMayo FJ,Hegemier SE, et al.Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia.Am J Respir Crit Care Med. 2001;164:155-161.
113. Ramsay PL,Luo Z,Magdaleno SM, et al.Transcriptional regulation of CCSP by interferon-gamma in vitro and in vivo.Am J Physiol Lung Cell Mol Physiol. 2003;284:L108-L118.
114. Roe MF,Bloxham DM,Cowburn AS, et al.Changes in helper lymphocyte chemokine receptor expression and elevation of IP-10 during acute respiratory syncytial virus infection in infants.Pediatr Allergy Immunol. 2010;22:229-234.
115. Roux X,Remot A,Petit-Camurdan A, et al.Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells.Eur J Immunol. 2011;41:2852-2861.
116. Rudd BD,Burstein E,Duckett CS, et al.Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.J Virol. 2005;79:3350-3357.
117. Sano H,Nagai K,Tsutsumi H, et al.Lactoferrin and surfactant protein a exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection.Eur J Immunol. 2003;33:2894-2902.
118. Schutte BC.McCray PB Jr. β-Defensins in lung host defense.Annu Rev Physiol. 2002;64:709-748.
119. Segovia J,Sabbah A,Mgbemena V, et al.TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection.PLoS One. 2012;7:e29695.
120. Sheeran P,Jafri H,Carubelli C, et al.Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease.Pediatr Infect Dis J. 1999;18:115-122.
121. Shijubo N,Itoh Y,Yamaguchi T, et al.Development of an enzyme-linked immunosorbent assay for Clara cell 10-kda protein: in pursuit of clinical significance of sera in patients with asthma and sarcoidosis.Ann N Y Acad Sci. 2000;923:268-279.
122. Scheerlinck JP,Snibson KJ,Bowles VM, et al.Biomedical applications of sheep models: from asthma to vaccines.Trends Biotechnol. 2008;26:259-266.
123. Schlender J,Bossert B,Buchholz U, et al.Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response.J Virol. 2000;74:8234-8242.
124. Schneberger D,Aharonson-Raz K,Singh B.Pulmonary intravascular macrophages and lung health: what are we missing?.Am J Physiol Lung Cell Mol Physiol. 2012;302 (6): L498-L503.
125. Schuurhof A,Bont L,Siezen CL, et al.Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls.Pediatr Pulmonol. 2010;45:608-613.
126. Schuurhof A,Janssen R,de Groot H, et al.Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze.Respir Res. 2011;12:121.
127. Semple MG,Dankert HM,Ebrahimi B, et al.Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P.PLoS One. 2007;2:e1038.
128. Singh G,Katyal SL.Clara cell proteins.Ann N Y Acad Sci. 2000;923:43-58.
129. Smiley-Jewell SM,Nishio SJ,Weir AJ, et al.Neonatal Clara cell toxicity by 4-ipomeanol alters bronchiolar organization in adult rabbits.Am J Physiol. 1998;274:L485-L498.
130. Smiley-Jewell SM,Plopper CG.Proliferation during early phases of bronchiolar repair in neonatal rabbits following lung injury by 4-ipomeanol.Toxicol Appl Pharmacol. 2003;192:69-77.
131. Sow FB,Gallup JM,Krishnan S, et al.Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs.Resp Res. 2011;12:106.
132. Sow FB,Gallup JM,Olivier A, et al.Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs.Am J Physiol Lung Cell Mol Physiol. 2011;300:L12-L24.
133. Sow FB,Gallup JM,Derscheid R, et al.Ontogeny of the immune response in the ovine lung.Immunol Invest. 2012;41:304-316.
134. Stavnezer J.Regulation of antibody production and class switching by TGF-beta.J Immunol. 1995;155:1647-1651.
135. Swedan S,Andrews J,Majumdar T, et al.Multiple functional domains and complexes of the two nonstructural proteins of human respiratory syncytial virus contribute to interferon suppression and cellular location.J Virol. 2011;85:10090-10100.
136. Tayyari F,Marchant D,Moraes TJ, et al.Identification of nucleolin as a cellular receptor for human respiratory syncytial virus.Nat Med. 2011;17:1132-1136.
137. Tekkanat KK,Maassab H,Miller A, et al.RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease.Eur J Immunol. 2002;32:3276-3284.
138. Thornburg NJ,Shepherd B,Crowe JE.Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection.J Virol. 2010;84:12895-12902.
139. Vareille M,Kieninger E,Edwards MR, et al.The airway epithelium: soldier in the fight against respiratory viruses.Clin Microbiol Rev. 2011;24 (1): 210-29.
140. Wahl SM,McCartney-Francis N,Allen JB, et al.Macrophage production of TGF-beta and regulation by TGF-beta.Ann N Y Acad Sci. 1990;593:188-196.
141. Wang SZ,Rosenberger CL,Bao YX, et al.Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection.J Immunol. 2003;171:1051-1060.
142. Wijkstrom-Frei C,El-Chemaly S,Ali-Rachedi R, et al.Lactoperoxidase and human airway host defense.Am J Respir Cell Mol Biol. 2003;29:206-212.
143. Willems F,Vollstedt S,Suter M.Phenotype and function of neonatal DC.Eur J Immunol. 2009;39:26-35.
144. You D,Becnel D,Wang K, et al.Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults.Respir Res. 2006;7:107-117.
145. Zhao DY,Wen GY,Tian M, et al.Association of RANTES gene promoter -28c/g polymorphism with respiratory syncytial virus bronchiolitis [in Chinese].Zhonghua Er Ke Za Zhi. 2008;46:89-93.